Innovations in Melanoma Treatment: The Role of TIL Therapy

Explore the cutting-edge developments in melanoma treatment with a focus on Tumor-Infiltrating Lymphocyte (TIL) therapy in this 29-minute lecture by Dr. Harriet Kluger, a renowned medical oncologist and international expert in melanoma immunotherapy. Learn from the director of Yale's SPORE in Skin Cancer as she discusses innovative approaches to reducing melanoma mortality through novel drug development, advanced treatment regimens for patients with advanced melanoma, and the identification of predictive biomarkers for optimizing treatment selection. Gain valuable insights into how these scientific advancements are transforming the landscape of melanoma care and improving patient outcomes.